CrossRef

Preventing Fractures in Diabetic Dialysis Patients

International Journal of Endocrinology and Metabolism 10(4) (2011)

E. Michael Lewiecki

Significant Effect of Raloxifene on Bone in Hemodialysis Patients

International Journal of Endocrinology and Metabolism 10(4) (2012)

Pernille Ravn

Efficacy of Osteoporosis Therapies in Diabetic Patients

Calcified Tissue International 100(2) (2017)

Ann V. Schwartz

The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease

Nature Reviews Endocrinology 21(5) (2025)

Jasna Aleksova; Peter Ebeling; Grahame Elder

Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients?

International Journal of Endocrinology and Metabolism 10(4) (2011)

Antonino Lasco; Antonino Catalano; Nancy Morabito

Untitled

Which Method is More Efficient in Determining Osteoporosis, QUS or DEXA?

International Journal of Endocrinology and Metabolism 10(4) (2012)

Cem Dane; Banu Dane

Safety of Raloxifene in Hemodialysis Patients

International Journal of Endocrinology and Metabolism 10(4) (2012)

Didy Jacobsen

Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Biology of Blood and Marrow Transplantation 26(10) (2020)

Merav Bar; Susan M. Ott; E. Michael Lewiecki; Kyriakie Sarafoglou; Joy Y. Wu; Matthew J. Thompson; Jonathan J. Vaux; David R. Dean; Kenneth G. Saag; Shahrukh K. Hashmi; Yoshihiro Inamoto; Bhagirathbhai R. Dholaria; Mohamed A. Kharfan-Dabaja; Arnon Nagler; Cesar Rodriguez; Betty K. Hamilton; Nina Shah; Mary E.D. Flowers; Bipin N. Savani; Paul A. Carpenter

The prevention of fragility fractures in diabetic patients

Aging Clinical and Experimental Research 27(2) (2015)

Stefano Gonnelli; Carla Caffarelli; Nicola Giordano; Ranuccio Nuti

Diabetes and Bone Disease

Endocrinology and Metabolism Clinics of North America 46(1) (2017)

G. Isanne Schacter; William D. Leslie

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D

Cochrane Database of Systematic Reviews 2021(7) (2021)

Takashi Hara; Yasukazu Hijikata; Yukiko Matsubara; Norio Watanabe

Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease

Kidney International 89(1) (2016)

Christopher L. Newman; Amy Creecy; Mathilde Granke; Jeffry S. Nyman; Nannan Tian; Max A. Hammond; Joseph M. Wallace; Drew M. Brown; Neal Chen; Sharon M. Moe; Matthew R. Allen

Raloxifene May Have Further Benefits in Women on Hemodialysis

International Journal of Endocrinology and Metabolism 10(4) (2012)

Roisin Worsley; Emorfia Gavrilidis; Jayashri Kulkarni

Gonadal Hormones in the Pathogenesis and Treatment of Bone Health in Patients with Chronic Kidney Disease: a Systematic Review and Meta-Analysis

Current Osteoporosis Reports 16(6) (2018)

Jasna Aleksova; Alexander J. Rodriguez; Robert McLachlan; Peter Kerr; Frances Milat; Peter R. Ebeling

Effectiveness of antiresorptive medications in women on long-term dialysis after hip fracture: A population-based cohort study

PLOS ONE 15(9) (2020)

Yu-Ciou Lin; Tien-Ching Lee; Chung-Yu Chen; Shun-Jin Lin; Shang-Jyh Hwang; Ming-Yen Lin; Yuanyuan Wang

Raloxifene in the Treatment of Osteoporosis in Postmenopausal Women with End-Stage Renal Disease: A Systematic Review and Meta-Analysis

Hormone and Metabolic Research 53(11) (2021)

Hao-Yang Ma; Shuang Chen; Ling-Ling Lu; Wei Gong; Ai-Hua Zhang

Effects of Raloxifene on Bone in Patients With Type 2 Diabetes

International Journal of Endocrinology and Metabolism 10(4) (2011)

Itsuo Gorai